Sept 19 (Reuters) - Aralez Pharmaceuticals Inc AZLG.F :
* ARALEZ PHARMACEUTICALS ENTERS INTO DEFINITIVE "STALKING HORSE" PURCHASE AGREEMENTS FOR SUBSTANTIALLY ALL ASSETS
* ARALEZ PHARMACEUTICALS INC - TRANSACTIONS VALUED AT AN AGGREGATE OF U.S. $240 MILLION
* ARALEZ PHARMACEUTICALS INC - COMPANY ALSO CONTINUES ITS EFFORTS TO SELL ASSETS NOT BEING SOLD IN PROPOSED STALKING HORSE TRANSACTIONS
* ARALEZ PHARMACEUTICALS INC - INTENDS TO WIND DOWN ITS OPERATIONS FOLLOWING CONSUMMATION OF SALES
* ARALEZ PHARMACEUTICALS INC - AGREEMENT TO SELL ITS VIMOVO ROYALTIES AND CANADIAN OPERATIONS TO NUVO PHARMACEUTICALS FOR U.S.$110 MILLION
* ARALEZ PHARMACEUTICALS INC - DEERFIELD PROVIDED COMMITMENT TO FINANCE NUVO'S TRANSACTION WITH CO
* ARALEZ PHARMACEUTICALS - AGREEMENT TO SELL TOPROL-XL FRANCHISE TO CERTAIN FUNDS MANAGED BY DEERFIELD MANAGEMENT CO IN TRANSACTION VALUED AT $130 MILLION
* ARALEZ PHARMACEUTICALS INC - CONTINUES ITS EFFORTS TO SELL ASSETS NOT BEING SOLD IN PROPOSED STALKING HORSE TRANSACTIONS
* ARALEZ PHARMACEUTICALS - NUVO, DEERFIELD TO SERVE AS "STALKING HORSE" BIDDERS THROUGH RESTRUCTURING PROCEEDINGS COMMENCED BY CO, CERTAIN AFFILIATES